ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Advanced Search

Articles tagged "Portal veins"

  • 2020 American Transplant Congress

    Evaluation of US Doppler Examination of Portal Flow Dynamics in Patients with Total Pancreatectomy and Autologous Islet Cell Transplant

    B. M. Williams, X. Baldwin, J. S. Vonderau, C. S. Desai

    University of North Carolina, Chapel Hill, NC

    *Purpose: The aim of this study is to evaluate US doppler flow dynamics following total pancreatectomy and autologous islet cell transplant (TPAIT) and establish any…
  • 2020 American Transplant Congress

    Systemic Venous versus Portal Venous Drainage in Simultaneous Pancreas-Kidney Transplantation: A Matched-Pair Analysis

    V. Gurram, K. Gurung, A. Farney, J. Rogers, G. Orlando, C. Jay, A. Reeves-Daniel, R. Stratta

    Abdominal Transplant Surgery, Wake Forest Baptist Health, Winston Salem, NC

    *Purpose: The study purpose was to evaluate outcomes in vascularized pancreas transplantation (PTx) with enteric exocrine drainage based on technique of venous delivery.*Methods: We retrospectively…
  • 2020 American Transplant Congress

    Renoportal Vein Graft for Complete Portal Vein Thrombosis: A Reproducible Technique for a Challenging Problem

    P. Mehta, M. Black, H. Fernandez, J. Bayer, A. Gupta, A. Wall, E. Martinez, N. Onaca, R. Ruiz, G. Testa, G. J. Mckenna

    Baylor University Medical Center, Dallas, TX

    *Purpose: Type-IV Yerdel portal vein thrombosis (PVT) was historically contraindicated in liver transplant due to lack of appropriate portal vein inflow. Renoportal vein graft (RPVG)…
  • 2020 American Transplant Congress

    Acute Portal Vein Thrombosis after Pediatric Living Donor Liver Transplantation: Re-Do Portal Vein Anastomosis vs Thrombectomy and Prophylactic Portal Vein Stenting Through Re-Opened Umbilical Vein- Breaching the Technical Barrier!

    A. Thorat, D. Mirza, V. Raut, K. Shah, A. Raj

    Organ Transplantation Center, Apollo Hospital New Mumbai, Mumbai, India

    *Purpose: Acute portal venous thrombosis (PVT) in perioperative period after living donor liver transplantation (LDLT) in pediatric patients is a serious complication. It can lead…
  • 2019 American Transplant Congress

    Large Series Of Liver Transplantation In Patients With Portal Vein Thrombosis

    Y. Cheah, C. J. Simon, R. L. Jenkins, M. E. Akoad

    Lahey Hospital & Medical Center, Burlington, MA

    *Purpose: Portal vein thrombosis (PVT) is common in the cirrhotic population and no longer considered an absolute contraindication to liver transplantation in most centers.*Methods: Retrospective…
  • 2019 American Transplant Congress

    CXCL12-CXCR4-Mediated Chemotaxis is a Potential Mechanism for Monocyte Recruitment in Ischemia-Reperfusion Injury in Orthotopic Liver Transplant Patients

    A. Q. Terry1, R. A. Sosa1, B. V. Naini1, V. Groysberg1, F. M. Kaldas2, R. W. Busuttil2, D. Gjertson1, J. Kupiec-Weglinski2, E. F. Reed1

    1Pathology and Laboratory Medicine, University of California, Los Angeles, Los Angeles, CA, 2Surgery, University of California, Los Angeles, Los Angeles, CA

    *Purpose: Ischemia-reperfusion injury (IRI) elicits cellular damage which lowers allograft survival in orthotopic liver transplant (OLT) patients. Damage-associated molecular patterns, such as high-mobility group box…
  • 2019 American Transplant Congress

    Outcomes of Portal Vein Extension Grafts in Pancreas Transplantation: A Single-Centre Analysis

    S. R. Punjala, B. L. Phillips, N. Karydis, F. Calder, C. J. Callaghan

    Department of Nephrology, Renal Transplantation and Urology, Guy's and St. Thomas' NHS Foundation Trust, London, United Kingdom

    *Purpose: Surgical dogma suggests that portal vein extension grafts (PVEGs) in pancreas transplantation should be strenuously avoided, though the evidence-base is lacking. In our unit,…
  • 2019 American Transplant Congress

    Portal Vein Thrombosis Discovered at Liver Transplant: Barrier to Success

    J. Seltman1, M. Kazimi2, J. Duque3, R. Cross2, A. Ray2, T. Ommert2, R. A. Rubin2

    1Mercer University Medical School, Macon, GA, 2Transplantation, Piedmont Transplant Institute, Atlanta, GA, 3Piedmont Heart Institute, Atlanta, GA

    *Purpose: Portal vein thrombosis (PVT) present at listing or diagnosed while listed enables potential treatment pre-liver transplant (OLT). Main PVT at OLT (mPVT) complicates surgeries…
  • 2019 American Transplant Congress

    Anticoagulation in Post-Liver Transplant Recipients with Portal Vein Thrombosis

    L. Schumacher1, L. Lindberg1, D. Alonso2, R. Gilroy3, J. Krong4, L. Dong4, S. LeCorchick1

    1Department of Pharmacy, Intermountain Medical Center, Murray, UT, 2Transplant Surgery, Intermountain Medical Center, Murray, UT, 3Transplant Hepatology, Intermountain Medical Center, Murray, UT, 4Department of Transplant, Intermountain Medical Center, Murray, UT

    *Purpose: The purpose of this study is to compare safety and efficacy outcomes in liver transplant recipients with portal vein thrombosis (PVT) at the time…
  • 2018 American Transplant Congress

    Balloon-Occluded Retrograde Transvenous Obliteration (BRTO) for the Treatment of Medically Refractory Hepatic Encephalopathy (HE) in Patients with ESLD and Significant Portal-Venous Shunting

    N. Presser, J. DiNorcia, V. Agopian, H. Yersiz, D. Farmer, R. Busuttil, F. Kaldas.

    Liver and Pancreas Transplantation, Dumont-UCLA Liver Transplant Center, Los Angeles, CA.

    Background: Patients with medical refractory HE represent a challenging group of patients. Plagued by repeated hospitalizations, long lengths of stay (LOS) and high healthcare costs,…
  • 1
  • 2
  • 3
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Subtherapeutic Low Tacrolimus Trough Levels (≤3.5 Ng /ml) Are A Risk Factor For Acute Rejection And Creatinine Doubling.
  • Penis Transplantation: First U.S. Experience.
  • Low GFR after Kidney Donation Is Not Chronic Kidney Disease
  • Is There a Difference Between DCD and DBD Kidney Transplantation with Similar KDPI?
  • Live Related Kidney Transplant Experience in Abuja, Nigeria – First Eight Cases Ever.
  • Subtherapeutic Low Tacrolimus Trough Levels (≤3.5 Ng /ml) Are A Risk Factor For Acute Rejection And Creatinine Doubling.
  • Penis Transplantation: First U.S. Experience.
  • Low GFR after Kidney Donation Is Not Chronic Kidney Disease
  • Is There a Difference Between DCD and DBD Kidney Transplantation with Similar KDPI?
  • Live Related Kidney Transplant Experience in Abuja, Nigeria – First Eight Cases Ever.
  • Tacrolimus Dose and Trough Blood Levels in a US Liver Transplant Population
  • The Efficacy and Safety of Plaquenil in Kidney Transplants Patients with Lupus.

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2021 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy

This site uses cookies: Find out more.